Literature DB >> 15514986

Mechanism for benzyl alcohol-induced aggregation of recombinant human interleukin-1 receptor antagonist in aqueous solution.

Ye Zhang1, Shouvik Roy, Latoya S Jones, Sampathkumar Krishnan, Bruce A Kerwin, Byeong S Chang, Mark C Manning, Theodore W Randolph, John F Carpenter.   

Abstract

Benzyl alcohol, an antimicrobial preservative, accelerates aggregation and precipitation of recombinant human interleukin-1 receptor antagonist (rhIL-1ra) in aqueous solution. The loss of native monomer during incubation at 37 degrees C was determined by analysis of sample aliquots with size exclusion high performance liquid chromatography (SE-HPLC). Benzyl alcohol caused minor perturbation of the tertiary structure of the protein without changing its secondary structure, documenting that the preservative caused a minor shift in the protein molecular population toward partially unfolded species. Consistent with this conclusion, in the presence of benzyl alcohol the rate of H-D exchange was accelerated and the fluorescence of 1-anilinonaphthalene-8-sulfonic acid in the presence of rhIL1ra was increased. Benzyl alcohol did not alter the free energy of unfolding based on unfolding experiments in urea or guanidine HCl. With differential scanning calorimetry it was determined that benzyl alcohol reduced the apparent Tm of rhIL-1ra, but this effect occurred because the preservative lowered the temperature at which the protein aggregated during heating. Isothermal calorimetry documented that the interaction of benzyl alcohol with rhIL-1ra is relatively weak and hydrophobically driven. Thus, benzyl alcohol accelerates protein aggregation by binding to the protein and favoring an increase in the level of partially unfolded, aggregation-competent species. Sucrose partially inhibited benzyl alcohol-induced aggregation and tertiary structural change. Sucrose is preferentially excluded from the surface of the protein, favoring most compact native state species over expanded aggregation-prone forms. (c) 2004 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15514986     DOI: 10.1002/jps.20219

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  16 in total

1.  Role of partial protein unfolding in alcohol-induced protein aggregation.

Authors:  Surinder M Singh; Javier Cabello-Villegas; Regina L Hutchings; Krishna M G Mallela
Journal:  Proteins       Date:  2010-09

2.  High-pressure studies of aggregation of recombinant human interleukin-1 receptor antagonist: thermodynamics, kinetics, and application to accelerated formulation studies.

Authors:  Matthew B Seefeldt; Yong-Sung Kim; Kevin P Tolley; Jim Seely; John F Carpenter; Theodore W Randolph
Journal:  Protein Sci       Date:  2005-08-04       Impact factor: 6.725

Review 3.  Factors affecting the physical stability (aggregation) of peptide therapeutics.

Authors:  Karolina L Zapadka; Frederik J Becher; A L Gomes Dos Santos; Sophie E Jackson
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

4.  Effect of antimicrobial preservatives on partial protein unfolding and aggregation.

Authors:  Regina L Hutchings; Surinder M Singh; Javier Cabello-Villegas; Krishna M G Mallela
Journal:  J Pharm Sci       Date:  2012-11-20       Impact factor: 3.534

5.  Chemical and thermal stability of insulin: effects of zinc and ligand binding to the insulin zinc-hexamer.

Authors:  Kasper Huus; Svend Havelund; Helle B Olsen; Marco van de Weert; Sven Frokjaer
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

6.  Mechanisms of m-cresol-induced protein aggregation studied using a model protein cytochrome c.

Authors:  Surinder M Singh; Regina L Hutchings; Krishna M G Mallela
Journal:  J Pharm Sci       Date:  2011-01-12       Impact factor: 3.534

7.  Effect of benzyl alcohol on recombinant human interleukin-1 receptor antagonist structure and hydrogen-deuterium exchange.

Authors:  John R Alford; Andrew C Fowler; Deborah S Wuttke; Bruce A Kerwin; Ramil F Latypov; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2011-05-05       Impact factor: 3.534

8.  Physical instability of a therapeutic Fc fusion protein: domain contributions to conformational and colloidal stability.

Authors:  Jonas L Fast; Amanda A Cordes; John F Carpenter; Theodore W Randolph
Journal:  Biochemistry       Date:  2009-12-15       Impact factor: 3.162

9.  Role of benzyl alcohol in the unfolding and aggregation of interferon α-2a.

Authors:  Regina L Bis; Surinder M Singh; Javier Cabello-Villegas; Krishna M G Mallela
Journal:  J Pharm Sci       Date:  2014-08-06       Impact factor: 3.534

10.  Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution.

Authors:  Renuka Thirumangalathu; Sampathkumar Krishnan; Margaret Speed Ricci; David N Brems; Theodore W Randolph; John F Carpenter
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.